Murphy & Mullick Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.69K Hold
4
– – ﹤0.01% 642
2026
Q2
$1.45K Hold
4
– – ﹤0.01% 629
2026
Q1
$1.41K Hold
4
– – ﹤0.01% 621
2025
Q4
$1.31K Hold
4
– – ﹤0.01% 635
2025
Q3
$1.13K Hold
4
– – ﹤0.01% 628
2025
Q2
$1.18K Hold
4
– – ﹤0.01% 617
2025
Q1
$1.25K Hold
4
– – ﹤0.01% 602
2024
Q4
$1.04K Buy
+4
New +$1.19K ﹤0.01% 601

Other funds holding AMGN

Murphy & Mullick Capital Management's AMGN Position: Q3 2026 in Review

Murphy & Mullick Capital Management held its Amgen (AMGN) position steady in Q3 2026 at 4 shares worth $1.69K. The position accounts for ﹤0.01% of the portfolio, ranked #642.

Murphy & Mullick Capital Management first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. 2,024 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Murphy & Mullick Capital Management held 4 shares of Amgen worth $1.69K as of Q3 2026.
  • Murphy & Mullick Capital Management left its Amgen share count unchanged in Q3 2026.
  • Amgen made up ﹤0.01% of Murphy & Mullick Capital Management's portfolio in Q3 2026, its #642 holding.
  • Murphy & Mullick Capital Management first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
  • 2,024 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q3 2026, filed 2 Nov 2026.